PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 244 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin to acquire Alesta Therapeutics

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Regeneron ends eye disease study due to antibody’s safety profile

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wall Street Analysts Think Takeda Pharmaceutical Co. (TAK) Could Surge 26.41%: Read This Before Placing a Bet

finance.yahoo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Substances Generally Recognized as Safe Proposed Rule

Office of Advocacy (.gov)Original source
🌍Industryorchestrabiomed.comTier 1 · Company source

Q2 2026 Progress Brings Key Pivotal Milestones Into View

Orchestra BioMedOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amylyx Shares Jump 45% Following Positive Phase 3 Trial Results for GLP-1 Blocker Avexitide

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Global $35+ Billion Pharmaceutical Electronic Manufacturing Services (EMS) Market Outlook, 2031

finance.yahoo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Analysts Offer Insights on Healthcare Companies: OmniAb (OABI), Neurocrine (NBIX) and Evaxion Biotech (EVAX)

The Globe and MailOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PhenoNet gets FDA green light for Phase 3 Alzheimer’s trial

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AC Immune’s Parkinson’s drug candidate Wins FDA Fast Track designation

Indian Pharma PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How waste feedstocks and biotech create circular cosmetic ingredients

Personal Care InsightsOriginal source
🌍Mediaskpharmteco.comTier 3 · Secondary coverage

SK pharmteco Marks Construction Progress with Ribbon Cutting for Two Advanced Manufacturing Facilities at Swords, Ireland Campus

SkpharmtecoOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is BioMarin Pharmaceutical stock surging today?

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Longevica Therapeutics Appoints Ex-Genentech Biotech Veteran Dr. Prasun Mishra as CEO to Advance World's Largest $13 Million Mammalian Longevity Study Toward Clinical Development

biospace.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nashik: Safe, Nutritious Food Mandatory In ZP Schools; CEO Omkar Pawar Orders Strict Compliance

Free Press JournalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca

fiercebiotech.comOriginal source
🇺🇸CROmedidata.comTier 2 · Direct publisher

The Impact of AI in Healthcare: What Are the Real-world Effects?

Medidata SolutionsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical to Acquire Alesta Therapeutics for up to $490 Million

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics may seek accelerated approval using tumor response data

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin to acquire Alesta for $275M upfront (BMRN:NASDAQ)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

OmniAb: Lilly-Style Partners Paying Attention To This Early-Stage Biotech (NASDAQ:OABI)

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

PharmTech.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Rebounding biotech funds expected to spur CDMO growth within year

BioSpaceOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Universität Heidelberg Achieves Top Placements in Shanghai Ranking

Heidelberg UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lipitor Lawsuit 2026: Payouts, Settlements, Claims

LawFold.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ACMA’s Data Provides: The Critical Data Layer Pharmaceutical Companies Need Now More Than Ever

manilatimes.netOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amylyx (AMLX) Stock Surges Past 52-Week High on Successful Avexitide Phase 3 Results

BlockonomiOriginal source
🌍Regulatorynafdac.gov.ngTier 1 · Regulatory source

Public Alert No: 039/2026 – Alert on the Risk of Drug Poisoning Associated with Concurrent Use of Gabapentinoids and Other Medicines

NAFDAC NigeriaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The 82x ROI Claim Every Oncology Sponsor Is About to Misread

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Breakthrough NAD Formula Propels Wonderfeel to No. 1 Fastest-Growing Biotech Company and No. 65 Overall on the 2026 Inc. 5000

PR NewswireOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks

Health Canada has seized several unauthorized drugs (including an oral emergency contraceptive drug,...

Health Canada Recalls and Safety AlertsOriginal source
🌍Researchpremier-research.comTier 2 · Direct publisher

Regulatory Operations: The Overlooked Half of Submission Readiness

Premier ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation

lincolnjournal.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Protect Pharmaceutical closes three acquisitions and shifts to the Arvia brand

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A drug developer with 30-plus years joins Entera for a planned osteoporosis Phase 3 trial

Stock TitanOriginal source
🌍Regulatorynafdac.gov.ngTier 1 · Regulatory source

Public Alert No. 038/2026 – Alert on Adulterated and Substandard Medicines- NITRAS, KADIN 2, ACEFYL and LORATADINE 24 Recalled by the Drug Regulatory Authority of Pakistan (DRAP)

NAFDAC NigeriaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ONO Pharmaceutical Co (OPHLF) Gets a Sell from Goldman Sachs

The Globe and MailOriginal source
🌍Researchanswers.childrenshospital.orgTier 2 · Direct publisher

Finding answers and care for a rare movement disorder: Aisha’s experience with deep brain stimulation

Boston Children's HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A model for successful credentialing in pharmacy

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Breaking Down the Barriers to Market Access in the Pharmaceutical Industry

the360mag.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Brokers Set Expectations for Edesa Biotech FY2026 Earnings

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Invivyd stock rating on trial progress

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Regeneron ends eye disease study after antibody shows ‘unfavorable’ risk/benefit profile

BioSpaceOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Survey of adult carers in England: 2025 to 2026 report

Official statistics on the opinions and experiences of unpaid carers aged 18 and over on topics that...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Biotech Leaders Can Learn From The Cockpit

Life Science LeaderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fadnavis nod to Tukaram Mundhe’s fierce crackdown on Maharashtra hotels, eateries

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Amylyx announces Lucidity Phase 3 trial met primary endpoint

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioBTX to build commercial-scale plant converting mixed plastic waste into pharmaceutical-grade BTX aromatics

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The EU Just Revoked Tavneos. What Did FDA Know During the Parallel Review?

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA: Fight against food adulteration cannot be left to us alone

CitiNewsroom.comOriginal source
🌍Devicesnews.henryschein.comTier 3 · Secondary coverage

Building a Healthier Future Together: Henry Schein and Special Olympics Renew Partnership Through 2030

Henry ScheinOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Boosting Domestic Manufacturing

PharmTech.comOriginal source
🇺🇸CROir.labcorp.comTier 3 · Secondary coverage

Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health

Labcorp Drug DevelopmentOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun-Biotech (SEHK:6990) Stock Rebound Meets Profit Quality Questions

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korean drugmakers cut costs as lower generic prices squeeze research budgets

Korea JoongAng DailyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Updated UK guidance for finerenone introduces new treatment for HF patients

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

After FDA Crackdowns, Karnataka Launches QR Code To Report Food & Drug Safety Violations Instantly

Health and MeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pallas Capital Advisors LLC Acquires New Position in West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source